PMO Interview with the Innovator Series: Volume 2
Peter Hirth, PhD
Video Categories: PMO Interview with the Innovator Series
Dr. Sanjiv Agarwala discusses the pros and cons of using Pembrolizumab over anti-CTLA4 antibody therapy.
Dr. S. Yosuf Zafar questions how to incorporate new agents into the standard of cancer care as many of these agents are both expensive and only useful for a small segment of patients.